Australia Backtracks On Cloning Patent For S. Korea Scientist
This article was originally published in PharmAsia News
Australian authorities are taking a new look at the recent decision to grant a stem cell patent to a disgraced South Korean scientist. Hwang Woo-suk, who lost his job and faced court action after it was revealed he falsified parts of his breakthrough cloning research, was granted an Australia patent for that human embryo cloning technology. IP Australia, the country's intellectual property arm, said the government has delayed the effective date for the patent to become official. The agency would not comment on the delay other than to say it was "investigating the matter." (Click here for more
You may also be interested in...
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.
Rosa DeLauro prevails over fellow Democrats Debbie Wasserman Schultz and Marcy Kaptur for Appropriations chair. Frank Pallone gets unanimous support from Democrats to continue as Energy and Commerce chair.
The US Medicare agency is offering more lower-cost alternative sites for 2021 surgical procedures to be covered under its OPPS and ASC final rule.